KalVista Pharmaceuticals, Inc. (KALV)
USD 10.32
(-10.26%)
USD 10.32
(-10.26%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -86.16 Million USD | -10644.01% |
| 2023 | -802 Thousand USD | -7.94% |
| 2022 | -743 Thousand USD | -106.17% |
| 2021 | 12.03 Million USD | -4.83% |
| 2020 | 12.64 Million USD | -21.39% |
| 2019 | 16.09 Million USD | 92.13% |
| 2018 | 8.37 Million USD | 461.63% |
| 2017 | 1.49 Million USD | -29.6% |
| 2016 | 2.11 Million USD | 17.97% |
| 2015 | 1.79 Million USD | 332.7% |
| 2014 | 415 Thousand USD | -73.02% |
| 2013 | 1.53 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | -816 Thousand USD | -1.75% |
| 2024 Q1 | -199 Thousand USD | 38.58% |
| 2024 Q2 | -197 Thousand USD | 1.01% |
| 2024 Q3 | -207 Thousand USD | -5.08% |
| 2024 Q4 | 987 Thousand USD | 576.81% |
| 2023 Q4 | -324 Thousand USD | -55.02% |
| 2023 FY | -802 Thousand USD | -7.94% |
| 2023 Q1 | -18.18 Million USD | -9892.31% |
| 2023 Q2 | -192 Thousand USD | 98.94% |
| 2023 Q3 | -209 Thousand USD | -8.85% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q1 | - USD | -100.0% |
| 2022 Q4 | -182 Thousand USD | 0.0% |
| 2022 FY | -743 Thousand USD | -106.17% |
| 2022 Q3 | - USD | 0.0% |
| 2021 Q4 | 12.69 Million USD | 0.0% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 FY | 12.03 Million USD | -4.83% |
| 2020 Q4 | 3.82 Million USD | 142.49% |
| 2020 FY | 12.64 Million USD | -21.39% |
| 2020 Q3 | 1.57 Million USD | -59.77% |
| 2020 Q2 | 3.92 Million USD | 16.36% |
| 2020 Q1 | 3.36 Million USD | 15.14% |
| 2019 Q2 | 5.59 Million USD | 50.4% |
| 2019 Q3 | 3.89 Million USD | -30.44% |
| 2019 FY | 16.09 Million USD | 92.13% |
| 2019 Q4 | 2.92 Million USD | -24.78% |
| 2019 Q1 | 3.71 Million USD | -23.18% |
| 2018 FY | 8.37 Million USD | 461.63% |
| 2018 Q1 | 96 Thousand USD | -15.79% |
| 2018 Q2 | 1.12 Million USD | 1073.96% |
| 2018 Q3 | 2.33 Million USD | 106.83% |
| 2018 Q4 | 4.84 Million USD | 107.64% |
| 2017 Q4 | 114 Thousand USD | -54.03% |
| 2017 Q3 | 248 Thousand USD | 0.0% |
| 2017 FY | 1.49 Million USD | -29.6% |
| 2017 Q2 | - USD | -100.0% |
| 2017 Q1 | 7000.00 USD | 0.0% |
| 2016 Q4 | 7000.00 USD | -12.5% |
| 2016 Q3 | 8000.00 USD | 14.29% |
| 2016 Q2 | 7000.00 USD | 0.0% |
| 2016 Q1 | 7000.00 USD | 0.0% |
| 2016 FY | 2.11 Million USD | 17.97% |
| 2015 Q4 | 7000.00 USD | -12.5% |
| 2015 Q1 | 5000.00 USD | -16.67% |
| 2015 FY | 1.79 Million USD | 332.7% |
| 2015 Q2 | 10 Thousand USD | 100.0% |
| 2015 Q3 | 8000.00 USD | -20.0% |
| 2014 Q4 | 6000.00 USD | -98.49% |
| 2014 FY | 415 Thousand USD | -73.02% |
| 2014 Q3 | 398 Thousand USD | 0.0% |
| 2013 FY | 1.53 Million USD | 0.0% |
| 2002 Q1 | 33.57 Million USD | 0.0% |
| 2002 Q2 | - USD | -100.0% |
| 2001 Q3 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | 171.523% |
| Jaguar Health, Inc. | 7.72 Million USD | 1215.575% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -12876.958% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -1723240.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 105.677% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 171.954% |
| ContextLogic Inc. | 59 Million USD | 246.046% |
| MiMedx Group, Inc. | 266.84 Million USD | 132.291% |
| MEI Pharma, Inc. | 49.32 Million USD | 274.685% |
| AlloVir, Inc. | -398 Thousand USD | -21550.0% |
| Novavax, Inc. | 639.93 Million USD | 113.465% |
| Aptorum Group Limited | -1.11 Million USD | -7630.145% |
| Ardelyx, Inc. | 106.66 Million USD | 180.786% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 135.793% |
| Psyence Biomedical Ltd. | -240.00 USD | -35902816.667% |
| Vaxcyte, Inc. | -75 Million USD | -14.889% |
| Precigen, Inc. | 106 Thousand USD | 81389.623% |
| Pharming Group N.V. | 220.1 Million USD | 139.148% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 16831.456% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 8639.841% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 178.496% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 52.501% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -16574.923% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 33.472% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -90.109% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -291.9% |
| Acelyrin, Inc. | -115 Thousand USD | -74827.826% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -14990.543% |
| Senti Biosciences, Inc. | -2.68 Million USD | -3111.592% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 2227.055% |
| AbCellera Biologics Inc. | 38.02 Million USD | 326.606% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -1695.894% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 71905.833% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 395.812% |
| Chimerix, Inc. | 324 Thousand USD | 26694.753% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 17472.379% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -104981.707% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -176.463% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -17413.618% |
| Elevation Oncology, Inc. | -39 Thousand USD | -220841.026% |
| Alkermes plc | 1.37 Billion USD | 106.268% |
| Fortress Biotech, Inc. | 57.85 Million USD | 248.941% |
| Fortress Biotech, Inc. | 57.85 Million USD | 248.941% |
| Agenus Inc. | 139.61 Million USD | 161.718% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 619.799% |
| Dyadic International, Inc. | 922.95 Thousand USD | 9435.971% |
| ImmuCell Corporation | 4.39 Million USD | 2059.996% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 509.131% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 18.805% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -49182.499% |
| Immix Biopharma, Inc. | -5468.00 USD | -1575741.258% |
| Incyte Corporation | 3.44 Billion USD | 102.504% |
| IO Biotech, Inc. | -756 Thousand USD | -11297.751% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -83.964% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -545.066% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -194900.905% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 12.269% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -156567.273% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 10844.015% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -16250.474% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 393.215% |
| NextCure, Inc. | -3.68 Million USD | -2238.952% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 552.486% |
| Onconetix, Inc. | -1.12 Million USD | -7544.577% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -197.456% |
| Opthea Limited | 21.72 Thousand USD | 396817.311% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -150210.505% |
| PureTech Health plc | -1.6 Million USD | -5275.359% |
| Pyxis Oncology, Inc. | -2 Million USD | -4208.35% |
| Seer, Inc. | 7.02 Million USD | 1326.227% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -857197.781% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 1194.74% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -2085.844% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 20422.406% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 182.774% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 163.7% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 11.122% |
| ChromaDex Corporation | 50.78 Million USD | 269.687% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -37040.948% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -11.043% |
| CRISPR Therapeutics AG | 240.95 Million USD | 135.76% |
| Precision BioSciences, Inc. | 40.47 Million USD | 312.905% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 12.22% |
| Innoviva, Inc. | 261.06 Million USD | 133.006% |
| Summit Therapeutics Inc. | -2.05 Million USD | -4103.268% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 2068.182% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 499.94% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -72620.291% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -60030.076% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 14248.933% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 127.47% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 3447.591% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -169720.654% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -1113.962% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -18057.814% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -828428.846% |
| Soligenix, Inc. | 97.31 Thousand USD | 88648.057% |
| Century Therapeutics, Inc. | -10.8 Million USD | -697.178% |
| Kura Oncology, Inc. | -849 Thousand USD | -10049.234% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -28.408% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -58517.007% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 187.003% |
| Autolus Therapeutics plc | -4.86 Million USD | -1670.434% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 308.203% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -51189.881% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 190.967% |
| GRI Bio, Inc. | 10.84 Million USD | 894.825% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 3492.42% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -891.907% |
| IGM Biosciences, Inc. | -211.66 Million USD | 59.29% |
| INmune Bio, Inc. | 155 Thousand USD | 55691.613% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 239.116% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -5620.475% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -13188.067% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -294246.519% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 21534.577% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -4216.984% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -27429.393% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 191.22% |
| Verastem, Inc. | -62 Thousand USD | -138879.032% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 3638.686% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -32914.176% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 2946.614% |
| Histogen Inc. | 3.76 Million USD | 2386.203% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 15054.901% |
| Surrozen, Inc. | -27.23 Million USD | -216.441% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1498.942% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -7051.501% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -235.973% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 529.718% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -4351768.687% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1520.392% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -128256.497% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 155.667% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 59199.451% |
| Apollomics, Inc. | 127 Thousand USD | 67948.031% |
| Amarin Corporation plc | 165.54 Million USD | 152.052% |
| Mesoblast Limited | -9.81 Million USD | -777.911% |
| Turnstone Biologics Corp. | 16.5 Million USD | 622.034% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 22.013% |
| Synaptogenix, Inc. | -6347.00 USD | -1357502.017% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -168854.902% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 153.399% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 104.902% |
| Better Therapeutics, Inc. | -2.72 Million USD | -3057.457% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 23.176% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 125.487% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -755220.827% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -1276.47% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -7676.805% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 1277.466% |
| Insmed Incorporated | 239.63 Million USD | 135.958% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 2508.245% |
| OmniAb, Inc. | 14.66 Million USD | 687.489% |
| Alector, Inc. | -95.05 Million USD | 9.348% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 168.593% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -98.254% |
| Zai Lab Limited | 170.9 Million USD | 150.419% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 205.24% |
| Aura Biosciences, Inc. | -1.29 Million USD | -6553.822% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 66382.308% |
| Immunic, Inc. | -111 Thousand USD | -77527.928% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 643.503% |
| Veracyte, Inc. | 248.14 Million USD | 134.724% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 98.767% |
| FibroGen, Inc. | 128.9 Million USD | 166.846% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -15277736.879% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -638.56% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 102.535% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 22250.9% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 124.249% |
| TG Therapeutics, Inc. | 219.1 Million USD | 139.326% |
| Galecto, Inc. | -830 Thousand USD | -10281.566% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -6121.444% |
| Fortrea Holdings Inc. | 424 Million USD | 120.322% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -15097.002% |
| XBiotech Inc. | -1.74 Million USD | -4840.768% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -7676.805% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -85.421% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -14.077% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 217.389% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 612.807% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 122.149% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -73.559% |
| Vaxxinity, Inc. | -2.23 Million USD | -3757.073% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 126.371% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -660.934% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 452.407% |
| NexImmune, Inc. | -1.02 Million USD | -8306.766% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 1595785.185% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -1112.654% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.762% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -128840.398% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -2326.556% |
| Ainos, Inc. | -253.73 Thousand USD | -33859.714% |
| Pluri Inc. | 322 Thousand USD | 26859.938% |
| Prothena Corporation plc | -129.2 Million USD | 33.308% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 270.885% |
| Celularity Inc. | 6.75 Million USD | 1375.603% |
| Rallybio Corporation | -150 Thousand USD | -57344.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | -164.259% |
| MeiraGTx Holdings plc | 287 Thousand USD | 30123.345% |
| Omeros Corporation | -69.77 Million USD | -23.486% |
| Humacyte, Inc. | -76.55 Million USD | -12.563% |
| Immunocore Holdings plc | 248.39 Million USD | 134.69% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -468.047% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 238.128% |
| Blueprint Medicines Corporation | 236.58 Million USD | 136.421% |
| CalciMedica, Inc. | -58 Thousand USD | -148463.793% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -5942.567% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 396.565% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -2929.782% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -179.174% |
| Pulmatrix, Inc. | -8.22 Million USD | -948.26% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -7264.701% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -21495.739% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 78.393% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 3204.463% |
| Cytokinetics, Incorporated | -322.59 Million USD | 73.289% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 10094.954% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -25168.915% |
| Vor Biopharma Inc. | -3.49 Million USD | -2367.554% |
| Roivant Sciences Ltd. | 109.23 Million USD | 178.882% |
| Evogene Ltd. | 1.39 Million USD | 6259.185% |
| ProKidney Corp. | -3.16 Million USD | -2619.06% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -96.227% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1356.628% |
| CorMedix Inc. | -205.56 Thousand USD | -41817.767% |
| BioLineRx Ltd. | 1.1 Million USD | 7876.805% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -9.528% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -261012.121% |
| Atai Life Sciences N.V. | -5000.00 USD | -1723240.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -70610.411% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -89657.292% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -6103.528% |
| Sagimet Biosciences Inc. | 2 Million USD | 4408.35% |
| MediciNova, Inc. | 979.7 Thousand USD | 8895.199% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -2.192% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -91028.973% |
| GeoVax Labs, Inc. | -20.72 Million USD | -315.849% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 135.237% |
| Biomea Fusion, Inc. | -4.2 Million USD | -1951.107% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 109.878% |
| Mereo BioPharma Group plc | 7.42 Million USD | 1260.342% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -27695.806% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -717958.333% |
| Absci Corporation | -41.84 Million USD | -105.9% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1723240.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -12.824% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -3401.3% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 140.315% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -9056.961% |
| Allakos Inc. | -6.14 Million USD | -1303.143% |
| Imunon, Inc. | -720 Thousand USD | -11867.556% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -24.887% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 118.106% |
| BioAtla, Inc. | -103.73 Million USD | 16.932% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -755220.827% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -48308.427% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 64.514% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -27606.431% |
| XOMA Corporation | 3.86 Million USD | 2331.728% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -22.946% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 682.446% |
| aTyr Pharma, Inc. | -2.38 Million USD | -3508.333% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 791.549% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -297027.586% |
| Viridian Therapeutics, Inc. | -1 Million USD | -8448.313% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 662823176.923% |
| Akari Therapeutics, Plc | -4000.00 USD | -2154075.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 113.529% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 44354.473% |
| UroGen Pharma Ltd. | 73.35 Million USD | 217.471% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -222.795% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 742279.156% |
| Orgenesis Inc. | -5.72 Million USD | -1405.1% |
| Entera Bio Ltd. | -56 Thousand USD | -153769.643% |
| GH Research PLC | -315 Thousand USD | -27254.603% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -45491.005% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -16312.762% |
| Xencor, Inc. | -85.26 Million USD | -1.064% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -38893.651% |
| Replimune Group, Inc. | -2.65 Million USD | -3145.461% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -8506.063% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 148.451% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 44354.473% |
| Portage Biotech Inc. | -54 Thousand USD | -159468.519% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -91028.973% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -22755.968% |
| OncoCyte Corporation | 413 Thousand USD | 20963.68% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -1916852.169% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -38813863.964% |
| Purple Biotech Ltd. | -196 Thousand USD | -43862.755% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 1060.827% |
| scPharmaceuticals Inc. | 9.78 Million USD | 980.873% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -724.963% |
| HilleVax, Inc. | -2.15 Million USD | -3896.614% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -88731.959% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -574193.522% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -12799.251% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -374539.13% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -1147850.483% |
| Savara Inc. | -44.26 Million USD | -94.675% |
| Curis, Inc. | 9.81 Million USD | 978.269% |
| Daré Bioscience, Inc. | 2.76 Million USD | 3211.259% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -68950.71% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -4883.632% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -37692.544% |
| BeiGene, Ltd. | 2.07 Billion USD | 104.145% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -2981.906% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 78.44% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 252.002% |
| Erasca, Inc. | -3.73 Million USD | -2208.869% |
| bluebird bio, Inc. | -4.03 Million USD | -2038.139% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -305261.826% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 104.525% |
| DBV Technologies S.A. | 15.72 Million USD | 647.857% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -305261.826% |
| Moderna, Inc. | 2.15 Billion USD | 103.998% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -9317.158% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 1176.28% |
| Molecular Templates, Inc. | 50.39 Million USD | 270.983% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -15975.933% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 164.406% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -1284.876% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -119.015% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 22.461% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -2301.533% |
| MacroGenics, Inc. | 50.52 Million USD | 270.537% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -1313.037% |
| Prime Medicine, Inc. | -147.9 Million USD | 41.742% |
| Aditxt, Inc. | -111.66 Thousand USD | -77069.085% |
| Adagene Inc. | 18.11 Million USD | 575.759% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 17757.172% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 161.459% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 154.593% |
| SciSparc Ltd. | 2.19 Million USD | 4023.816% |
| Vericel Corporation | 135.57 Million USD | 163.556% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -343893.772% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -278019.553% |
| Generation Bio Co. | -73.91 Million USD | -16.582% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -19617.849% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 257.76% |
| Invivyd, Inc. | -2.02 Million USD | -4148.866% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 71.358% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -83203.041% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 189.415% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 187.668% |
| ADMA Biologics, Inc. | 88.21 Million USD | 197.675% |
| Clene Inc. | 533 Thousand USD | 16266.417% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 457.403% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -8903.866% |
| GeoVax Labs, Inc. | -20.72 Million USD | -315.849% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 4434.356% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -44243.749% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 273.009% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -1114.989% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -10207.057% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 203.299% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 117956.166% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 262.084% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 50.247% |
| Trevena, Inc. | 1.45 Million USD | 6022.131% |
| Surrozen, Inc. | -27.23 Million USD | -216.441% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -24309.915% |
| Cingulate Inc. | -582.91 Thousand USD | -14682.011% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -277858.065% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -337.418% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -1138169.485% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -9680.59% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 112.658% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -8621.356% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -152835.643% |
| Kronos Bio, Inc. | 1.37 Million USD | 6380.394% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -60.562% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -29409.247% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -17545.818% |
| ImmunityBio, Inc. | -17.89 Million USD | -381.649% |
| Korro Bio, Inc. | -3.63 Million USD | -2273.747% |
| Kineta, Inc. | 5.43 Million USD | 1685.993% |
| BioVie Inc. | -229.37 Thousand USD | -37465.667% |
| Codexis, Inc. | 57.33 Million USD | 250.29% |
| Celularity Inc. | 6.75 Million USD | 1375.603% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 2247.197% |
| Celcuity Inc. | -142.77 Thousand USD | -60252.87% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 170424.175% |
| Cibus, Inc. | 1.42 Million USD | 6159.564% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -22939.305% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -275.963% |
| IN8bio, Inc. | -2.5 Million USD | -3345.302% |
| Kodiak Sciences Inc. | -25.94 Million USD | -232.088% |
| Annexon, Inc. | -3.26 Million USD | -2537.496% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -4115.607% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -106.452% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 13563.594% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 111.068% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 149.82% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -4435.105% |
| Arcellx, Inc. | 108.27 Million USD | 179.579% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -166.202% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 208.791% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -307.37% |
| Moolec Science SA | -143.3 Thousand USD | -60028.397% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -103.618% |
| Geron Corporation | -123.5 Million USD | 30.231% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 2721.448% |
| Royalty Pharma plc | 1.79 Billion USD | 104.803% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -22.938% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -2385475.858% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 37338.7% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 22.661% |
| Humacyte, Inc. | -76.55 Million USD | -12.563% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -8978.104% |
| 89bio, Inc. | -273 Thousand USD | -31463.004% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -6754.972% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -10061.203% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -69954.472% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 7800.357% |
| Notable Labs, Ltd. | 113 Thousand USD | 76353.982% |
| Liquidia Corporation | 14.6 Million USD | 690.185% |
| Mustang Bio, Inc. | -2.22 Million USD | -3772.674% |
| Immunovant, Inc. | -231 Thousand USD | -37201.732% |
| Quantum-Si incorporated | 488 Thousand USD | 17757.172% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -55.091% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -287123.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 4727.658% |
| Acasti Pharma Inc. | -11 Thousand USD | -783236.364% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -42011.359% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -13188.067% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 48.561% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 7694.617% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -22516.01% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -4300.766% |
| PepGen Inc. | -1.18 Million USD | -7177.618% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -67748.031% |
| United Therapeutics Corporation | 2.07 Billion USD | 104.163% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -276.324% |
| Solid Biosciences Inc. | -76.56 Million USD | -12.544% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -104239.876% |
| Immuneering Corporation | -764.13 Thousand USD | -11176.366% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 130135.917% |
| Belite Bio, Inc | -399 Thousand USD | -21495.739% |
| XOMA Corporation | 3.86 Million USD | 2331.728% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -330.061% |
| Bionomics Limited | -434.44 Thousand USD | -19733.628% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -7922.998% |
| uniQure N.V. | 2.21 Million USD | 3990.158% |
| Cassava Sciences, Inc. | -89.42 Million USD | 3.641% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 6.41% |
| Forte Biosciences, Inc. | -9000.00 USD | -957311.111% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -10219.401% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -19617.849% |
| Altimmune, Inc. | -65.37 Million USD | -31.808% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 123.801% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -7922.998% |
| Compugen Ltd. | 31.45 Million USD | 373.937% |
| Peak Bio, Inc. | 367.76 Thousand USD | 23529.653% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 451.473% |
| Benitec Biopharma Inc. | 108 Thousand USD | 79884.259% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -110370.513% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -7062.677% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -4629.254% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -72309.244% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -7062.677% |
| Instil Bio, Inc. | -4.75 Million USD | -1711.754% |
| argenx SE | 1.1 Billion USD | 107.773% |
| Immunome, Inc. | -8.9 Million USD | -867.408% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -4459.101% |
| Verona Pharma plc | -679.62 Thousand USD | -12578.628% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -49138.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | -3512.872% |
| CervoMed Inc. | -1.29 Million USD | -6560.884% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -3479.85% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -1703.789% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 3587.131% |
| Moolec Science SA | -143.3 Thousand USD | -60028.397% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -21017.81% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -3125.383% |
| AnaptysBio, Inc. | 14.78 Million USD | 682.958% |
| Design Therapeutics, Inc. | -537 Thousand USD | -15945.996% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -20079.625% |
| NeurAxis, Inc. | 2.15 Million USD | 4095.31% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 4115.238% |
| Lumos Pharma, Inc. | 2 Million USD | 4393.323% |
| Achilles Therapeutics plc | -4.73 Million USD | -1721.225% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -49138.286% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -81439.626% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 372.174% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 10094.954% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -8249.516% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -89.178% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 200488.372% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -10382.603% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -654763.961% |
| Palisade Bio, Inc. | 246 Thousand USD | 35127.236% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -261012.121% |
| Beam Therapeutics Inc. | -59.67 Million USD | -44.401% |
| Neurogene Inc. | -3.26 Million USD | -2541.539% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 161.842% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -2233.884% |
| Sesen Bio, Inc. | 40 Million USD | 315.418% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -28912.458% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -2039.712% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -800.763% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 711.982% |
| Athira Pharma, Inc. | -969 Thousand USD | -8792.363% |
| Vaccinex, Inc. | -16 Million USD | -438.409% |
| HCW Biologics Inc. | -574.82 Thousand USD | -14890.154% |
| XOMA Corporation | 3.86 Million USD | 2331.728% |
| Nektar Therapeutics | 53.47 Million USD | 261.126% |
| Arvinas, Inc. | 71.8 Million USD | 220.01% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -3.242% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -37.263% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -26659.938% |
| Rezolute, Inc. | -36 Thousand USD | -239252.778% |
| Clene Inc. | 533 Thousand USD | 16266.417% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -6710725.545% |
| BeyondSpring Inc. | 1.75 Million USD | 5021.017% |
| Synlogic, Inc. | -1.92 Million USD | -4378.534% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -232783.784% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -1260.818% |
| Peak Bio, Inc. | 367.76 Thousand USD | 23529.653% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -354.395% |
| Krystal Biotech, Inc. | 47.6 Million USD | 281.004% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 161.072% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 1814.766% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -3227.915% |
| MannKind Corporation | 136.19 Million USD | 163.269% |
| Ikena Oncology, Inc. | -50.49 Million USD | -70.655% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 179.187% |
| Gossamer Bio, Inc. | -4.38 Million USD | -1865.04% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -34093.254% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1723240.0% |
| Legend Biotech Corporation | 140.92 Million USD | 161.142% |
| Mural Oncology plc | -2.56 Million USD | -3256.72% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -15538.294% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -86067.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 515.183% |
| REGENXBIO Inc. | 53.02 Million USD | 262.49% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1508.508% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -44691.163% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -4875.0% |
| Vaxart, Inc. | -60.76 Million USD | -41.808% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -32690.547% |
| Cellectis S.A. | 18 Thousand USD | 478805.556% |
| Longeveron Inc. | 221 Thousand USD | 39089.593% |
| Repare Therapeutics Inc. | -80.07 Million USD | -7.615% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 107.884% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -6558.964% |
| Revolution Medicines, Inc. | -399.66 Million USD | 78.44% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -246091.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 175951.02% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 101.001% |
| Denali Therapeutics Inc. | -93.34 Million USD | 7.69% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -343893.772% |
| Veru Inc. | 7.56 Million USD | 1238.882% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -56964.238% |
| Cingulate Inc. | -582.91 Thousand USD | -14682.011% |
| Passage Bio, Inc. | -3.72 Million USD | -2215.695% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -715335.071% |
| Exicure, Inc. | -1.42 Million USD | -5955.306% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -22397.911% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 3287.828% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -16707.334% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 226.482% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -57495.567% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -45.538% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 22137.596% |
| OmniAb, Inc. | 14.66 Million USD | 687.489% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 530.986% |
| Lipocine Inc. | -2.85 Million USD | -2922.536% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -4575.366% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -1410.377% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -5620.475% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 214.407% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -132464.615% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 202.22% |
| Ocugen, Inc. | -33.53 Million USD | -156.931% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -2625.079% |
| Q32 Bio Inc. | 578 Thousand USD | 15007.785% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -32415.849% |
| Alumis Inc. Common Stock | -1.28 Million USD | -6610.826% |
| Equillium, Inc. | 35.95 Million USD | 339.632% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -4947.862% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 17310.029% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -2084249.299% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -33169.112% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 20484.328% |
| Dominari Holdings Inc. | 2.03 Million USD | 4325.944% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -46864.915% |
| vTv Therapeutics Inc. | -13.59 Million USD | -533.814% |
| Bio-Techne Corporation | 773.07 Million USD | 111.146% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 597.529% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 118.7% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -7271.001% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -259.329% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 836.659% |
| Nkarta, Inc. | -5.86 Million USD | -1368.172% |
| BioCardia, Inc. | -7.24 Million USD | -1088.674% |
| Iterum Therapeutics plc | -1.75 Million USD | -4823.829% |